New genetic variants in the apoA-I and apoC-III genes and familial combined hyperlipidemia

New genetic variants in the apoA-I and apoC-III genes and familial combined hyperlipidemia

Linkage and association between the apolipoprotein (apo) A-I/C-III/A-IV gene region on chromosome 11 and familial combined hyperlipidemia (FCHL) has been observed previously. Using sequence analysis two new allelic variants were identified, C317-T in intron 2 of the apoA-I gene and C1100-T in exon 3...

Full description

Bibliographic Details
Main Authors:	Martine Groenendijk, Rita M. Cantor, Tjerk W.A. De Bruin, Geesje M. Dallinga-Thie
Format:	Article
Language:	English
Published:	Elsevier 2001-02-01
Series:	Journal of Lipid Research
Subjects:	haplotypes polymorphism apolipoproteins
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520316783

Similar Items

Association of plasma lipids and apolipoproteins with the insulin response element in the apoC-III promoter region in familial combined hyperlipidemia
by: M. Groenendijk, et al.
Published: (1999-06-01)

ApoC-III deficiency prevents hyperlipidemia induced by apoE overexpression
by: Gery Gerritsen, et al.
Published: (2005-07-01)

Antisense inhibition of apoB synthesis with mipomersen reduces plasma apoC-III and apoC-III-containing lipoproteins
by: Jeremy D. Furtado, et al.
Published: (2012-04-01)

Evidence for a complex relationship between apoA-V and apoC-III in patients with severe hypertriglyceridemia
by: Frank G. Schaap, et al.
Published: (2006-10-01)

ApoE2-associated hypertriglyceridemia is ameliorated by increased levels of apoA-V but unaffected by apoC-III deficiency*
by: Gery Gerritsen, et al.
Published: (2008-05-01)

Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans
by: Jeffrey S. Cohn, et al.
Published: (2003-10-01)

Effects of apoA-V on HDL and VLDL metabolism in APOC3 transgenic mice1
by: Shen Qu, et al.
Published: (2007-07-01)

Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL
by: Marit Westerterp, et al.
Published: (2006-06-01)

Effects of atorvastatin versus fenofibrate on apoB-100 and apoA-I kinetics in mixed hyperlipidemia
by: Stefan Bilz, et al.
Published: (2004-01-01)

Human apoA-I expression in CETP transgenic rats leads to lower levels of apoC-I in HDL and to magnification of CETP-mediated lipoprotein changes1
by: David Masson, et al.
Published: (2006-02-01)

ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance
by: Bastian Ramms, et al.
Published: (2019-08-01)

Synthesis and secretion of apoC-I and apoE by human SW872 liposarcoma cells
by: Wassef, Hanny
Published: (2004)

Use of Intralipid for kinetic analysis of HDL apoC-III: evidence for a homogeneous kinetic pool of apoC-III in plasma
by: Minh N. Nguyen, et al.
Published: (2006-06-01)

Storage of human plasma samples leads to alterations in the lipoprotein distribution of apoC-III and apoE
by: Jeffrey S. Cohn, et al.
Published: (2004-08-01)

ApoE and ApoC-I polymorphisms: association of genotype with cardiovascular disease phenotype in African Americans
by: Erdembileg Anuurad, et al.
Published: (2009-07-01)

Active plasma phospholipid transfer protein is associated with apoA-I- but not apoE-containing lipoproteins
by: Marian C. Cheung, et al.
Published: (2006-06-01)

Biological and genetic determinants of serum apoC-III concentration: reference limits from the Stanislas Cohort
by: Peggy Tilly, et al.
Published: (2003-02-01)

Metabolsim of apoB and apoC lipoproteins in man: kinetic studies in normal and hyperlipoproteininemic subjects
by: M Berman, Ph.D., et al.
Published: (1978-01-01)

The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore
by: Chao-Qiang Lai, et al.
Published: (2003-12-01)

Identification of Rev-erbα as a physiological repressor of apoC-III gene transcription1
by: Eric Raspé, et al.
Published: (2002-12-01)

ApoA-I deficiency in mice is associated with redistribution of apoA-II and aggravated AApoAII amyloidosis[S]
by: Yaoyong Wang (王耀勇), et al.
Published: (2011-08-01)

Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis
by: Eftaxia-Konstantina Valanti, et al.
Published: (2018-10-01)

ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan
by: Katherine Olin-Lewis, et al.
Published: (2002-11-01)

Quality control in the apoA-I secretory pathway
by: Shaila Bhat, et al.
Published: (2004-07-01)

Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I*
by: Brian J. Van Lenten, et al.
Published: (2008-11-01)

ApoA-IV modulates the secretory trafficking of apoB and the size of triglyceride-rich lipoproteins
by: Richard B. Weinberg, et al.
Published: (2012-04-01)

Inhibition of collar-induced carotid atherosclerosis by recombinant apoA-I cysteine mutants in apoE-deficient mice[S]
by: Xinbo Zhang, et al.
Published: (2010-12-01)

LPL gene variants affect apoC-III response to combination therapy of statins and fenofibric acid in a randomized clinical trial of individuals with mixed dyslipidemia
by: Ariel Brautbar, et al.
Published: (2012-03-01)

ApoE and apoC-III-defined HDL subtypes: a descriptive study of their lecithin cholesterol acyl transferase and cholesteryl ester transfer protein content and activity
by: Mateo Amaya-Montoya, et al.
Published: (2020-05-01)

Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expression
by: Fayanne E. Thorngate, et al.
Published: (2003-12-01)

Hyperlipidemia in APOE2 transgenic mice is ameliorated by a truncated apoE variant lacking the C-terminal domain
by: Gery Gerritsen, et al.
Published: (2003-02-01)

Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA[S]
by: Ruud S. Kootte, et al.
Published: (2015-03-01)

Identification of ApoA4 as a sphingosine 1-phosphate chaperone in ApoM- and albumin-deficient mice
by: Hideru Obinata, et al.
Published: (2019-11-01)

Secretion of apoB- and apoA-I-containing lipoproteins by chick kidney
by: Patrizia Tarugi, et al.
Published: (1998-04-01)

Apoc2 loss-of-function zebrafish mutant as a genetic model of hyperlipidemia
by: Chao Liu, et al.
Published: (2015-08-01)

How do apolipoproteins ApoB I ApoA-I perform in patients with acute coronary syndromes
by: Sypniewska Grazyna, et al.
Published: (2011-01-01)

Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL
by: Jimmy F.P. Berbée, et al.
Published: (2005-02-01)

APOA5 polymorphisms influence plasma triglycerides in young, healthy African Americans and whites of the CARDIA Study
by: Kathy L.E. Klos, et al.
Published: (2005-03-01)

Endothelial lipase is less effective at influencing HDL metabolism in vivo in mice expressing apoA-II
by: Uli C. Broedl, et al.
Published: (2006-10-01)

Intestinal basolateral lipid substrate transport is linked to chylomicron secretion and is regulated by apoC-III
by: Diana Li, et al.
Published: (2019-09-01)

Cannot write session to /tmp/vufind_sessions/sess_o2ofr7sa8updnvrcmssfrvdjvi